STOCK TITAN

[8-K] ALLURION TECHNOLOGIES, INC. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Analyzing...
Positive
  • None.
Negative
  • None.
false 0001964979 0001964979 2025-09-30 2025-09-30 0001964979 alur:CommonStockParValue0.0001PerShareMember 2025-09-30 2025-09-30 0001964979 alur:WarrantsToPurchase0.056818SharesOfCommonStockEachAtAnExercisePriceOf202.50PerShareOfCommonStockMember 2025-09-30 2025-09-30
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 30, 2025

 

 

Allurion Technologies, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-41767   92-2182207
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

11 Huron Drive  
Natick, Massachusetts   01760
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s Telephone Number, Including Area Code: (508) 647-4000

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 


Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common stock, par value $0.0001 per share   ALUR   The New York Stock Exchange
Warrants to purchase 0.056818 shares of common stock, each at an exercise price of $202.50 per share of common stock   ALUR WS   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 
 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers

On September 30, 2025, Milena Alberti-Perez, a Class III member of the board of directors (the “Board”) of Allurion Technologies, Inc. (the “Company”), notified the Company of her resignation from the Board and her role as the chairperson of the Audit Committee of the Board (the “Audit Committee”), effective September 30, 2025. Ms. Alberti-Perez’s resignation was not the result of any disagreement with management or the Board or on any matter relating to the Company’s operations, policies or practices.

Ms. Alberti-Perez resigned to focus her time in the media sector, including a new position on the board of another public company in that sector. Such resignation and resulting reduction in the size of the Board aligns with the Board’s determination that a smaller board will improve efficiency and reduce director compensation costs. Effective upon Ms. Alberti-Perez’s resignation, the size of the Board will be reduced from nine to eight. The Board is currently evaluating which of its directors will replace Ms. Alberti-Perez as chairperson of the Audit Committee.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:  October 3, 2025     By:  

/s/ Brendan M. Gibbons

     

Name: Brendan M. Gibbons

Title: Chief Legal Officer

ALLURION TECHNOLOGIES INC

NYSE:ALUR

ALUR Rankings

ALUR Latest News

ALUR Latest SEC Filings

ALUR Stock Data

15.76M
6.96M
10.26%
40.98%
1.36%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NATICK